S. Romain et al., PROGNOSTIC VALUE OF CYTOSOLIC TYROSINE KINASE-ACTIVITY IN 249 NODE-POSITIVE BREAST-CANCER PATIENTS, British Journal of Cancer, 70(2), 1994, pp. 304-308
Tyrosine-specific protein kinase (TPK) has been associated with the cy
toplasmic domain of growth factor receptors as well as oncoproteins. E
nzymatic activation appears to be a major initial event in these signa
l transduction pathways. In this study, TPK was determined in the cyto
sols of 249 node-positive primary breast rumours. Enzyme activity was
measured using [P-32]ATP and poly(glutamic acid-tyrosine) (4:1) as an
artificial substrate. Levels of TPK varied from 0 to 35.9 pmol ATP min
(-1) mg(-1) protein (median 11.4). No correlation was found with tumou
r size or number of positive lymph nodes. In contrast, levels of TPK w
ere negatively associated with age (P=0.01) and menopausal status (P<0
.05) of the patients. Higher concentrations of TPK were in addition fo
und in tumours negative for oestradiol (P<0.01) and progesterone (P<0.
05) receptors. Finally, a positive correlation was found between TPK a
nd urokinase plasminogen activator (UPA) (P<0.05). Patients whose tumo
urs contained high levels of TPK had reduced disease-free (P = 0.01) a
nd overall survival (P<0.05). In Cox multivariate analysis, including
patient's age, menopausal status, tumour size, number of positive lymp
h nodes, steroid receptors and UPA, TPK retained its independent progn
ostic importance.